Efficacy of spectinomycin against Mycoplasma bovis induced pneumonia in conventionally reared calves.
Sixteen 3-week-old calves were intratracheally inoculated with Mycoplasma bovis. Follow-up consisted of regular bronchoalveolar lavages (BALs) and clinical examinations. Animals were slaughtered from 4 to 21 days after inoculation. Counts were made of the mycoplasmas and other bacteria systematically isolated from the BAL liquids and lung lobes after slaughter. On the 6th day, spectinomycin 20mg/kg was given intramuscularly in three repeated doses at 24h intervals to six randomly chosen calves. All animals had developed a persistent M. bovis infection with a maximum BAL count on the 6th day (start of treatment). Co-occuring Pasteurella multocida infection was found in most animals with a maximum rate on the 14th day. The extent of lung surface lesions varied widely (0-64%) but was greater in the later slaughtered calves. Average counts of M. bovis and P. multocida in the BAL liquids were lower in treated calves than in untreated ones but the difference was not statistically significant. However, M. bovis and P. multocida counts in the lungs of the treated group were significantly lower than in the untreated group (p=0.003 and 0.009, respectively).
Agence Française de Sécurité Sanitaire des Aliments, Site de Lyon, 31 av. Tony Garnier, F-69364 Cedex 07, Lyon, France. f.poumarat@lyon.afssa.fr
F
F
Poumarat
D
D
Le Grand
S
S
Philippe
D
D
Calavas
F
F
Schelcher
P
P
Cabanié
P
P
Tessier
H
H
Navetat
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018893:Bronchoalveolar Lavage / Q000662:veterinary; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy*; D007273:Injections, Intramuscular / Q000662:veterinary; D009174:Mycoplasma / Q000187:drug effects; D016979:Pasteurella multocida; D012766:Pasteurellosis, Pneumonic / Q000150:complications; D011019:Pneumonia, Mycoplasma / Q000150:complications / Q000188:drug therapy / Q000662:veterinary*; D000198:Spectinomycin / Q000008:administration & dosage / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000198:Spectinomycin